Description
SR 9011 research compound
SR 9011 is a synthetic agonist of the nuclear receptors Rev-Erbα and Rev-Erbβ, which regulate circadian rhythm and metabolic gene expression.
Product details
| Compound | SR-9011 |
|---|---|
| Class | Rev-Erb α/β agonist |
| Form | Tablets; Capsule; Liquid; Injectables; Transdermal |
| Strength | 20mg per tablet/27ct/540mg; 20mg per tablet/54ct/1080mg; 20mg per capsule/60ct/1.2g; 15ml/17mg per ml/250mg; 30ml/33mg per ml/1000mg; 10ml/64mg per ml = 640mg; 60mg/17mg per ml/1000mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What SR 9011 research has examined
- Circadian biology: clock-gene regulation in mice.
- Metabolism: energy expenditure in rodent models.
- Oncology research: cancer-cell viability studies.
Research interest does not establish a proven effect in humans.
Regulatory status
SR 9011 is not an approved medicine. It is supplied only as a research chemical for laboratory use.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from heat and light.
Related research products
T3 Liothyronine Sodium + SR-9011 + Yohimbine · T3 Liothyronine Sodium + 5a-Hydroxy Laxogenin + SR-9011 + GW-0742 + Yohimbine Transdermal · Stenabolic (SR-9009) + Cardarine (GW-501516) · All transdermals
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.